Allergic rhinitis, an increasingly prevalent health issue, affects the quality of life for hundreds of millions worldwide. With environmental changes and lifestyle shifts, the incidence of this condition has been rising annually, making it a key focus in medical research.
On the afternoon of March 6, 2024, a delegation including Mr. Ren Hui, CEO of Japan's Sanga Holdings Co., Ltd., and Dr. Nobuharu Sakaguchi, Chairman of Medical Corporation SSC and specially appointed ENT expert, visited Renshu Eye, Ear, Nose & Throat Hospital (Shanghai Changning Branch) for an exchange visit. The delegation engaged in academic discussions on cutting-edge treatments for allergic rhinitis, sharing the latest concepts and clinical practices between China and Japan, with the aim of improving treatment outcomes and quality of life for patients.
Accompanied by Sissi, Operating Dean of Renshu ENT Shanghai, Dr. Sakaguchi and his team toured the hospital's consultation rooms and diagnostic equipment, gaining detailed insights into the minimally invasive surgery center and overall service processes.
Subsequently, Prof. Lu Yongtian, a specially appointed expert at Renshu Eye, Ear, Nose & Throat Hospital and affiliated with Shenzhen Second People’s Hospital, and Dr. Sakaguchi Nobuharu, a specially appointed ENT expert from Japan, shared new insights and practical experiences in surgical techniques for allergic rhinitis. Together with Prof. Shen Wei, Medical Director of Renshu ENT, and Prof. Sun Guangbin, a specially appointed expert from Huashan Hospital affiliated with Fudan University, they engaged in in-depth discussions and exchanges on various nasal surgical approaches. They also shared expertise on preoperative, intraoperative, and postoperative care for nasal surgeries.The Japanese delegation expressed strong recognition and approval of Renshu’s postoperative care protocols and comprehensive comfort-oriented management in its surgical center.
As a domestic chain group specializing in ENT and minimally invasive surgery centers, Renshu Medical consistently adheres to its core values of "Safety, Efficiency, and Compassion." Certified by both "DNV Healthcare Quality" and "SGS Service Quality" international standards, the group is equipped with advanced medical devices and a highly qualified team. By integrating cutting-edge minimally invasive technologies, Renshu provides accurate diagnoses and optimal treatment plans, incorporating warmth into every detail to elevate the patient experience.
The Japanese delegation expressed strong agreement with Renshu's values, noting their alignment with Japan's medical service philosophy. They emphasized treating patients like family—delivering meticulous, compassionate care while considering individual differences, disease severity, and treatment side effects to tailor the most suitable solutions. Both sides reached consensus on enhancing surgical safety, minimizing patient discomfort, and accelerating postoperative recovery.
Through this Sino-Japanese academic exchange, the two parties will actively pursue international collaboration to share breakthroughs in allergic rhinitis diagnosis and treatment. By jointly advancing innovative surgical techniques, they aim to continuously improve medical services, offering personalized, high-quality care to help patients overcome allergic rhinitis and achieve better health outcomes.
